Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending August 2011. The report details a specific corporate action regarding the repurchase and cancellation of the company's ordinary shares, executed under shareholder authority granted at the Annual General Meeting on May 5, 2011.
Key Financial Metrics
The filing does not provide comprehensive financial statements such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share repurchase transaction:
- Shares Purchased: 2,400,000 ordinary shares of 25 pence each.
- Transaction Date: August 10, 2011.
- Price Range: Highest price paid was 1,268 pence per share; lowest price paid was 1,211 pence per share.
Material Changes
Following the cancellation of the repurchased shares, the company's capital structure changed as follows:
- Treasury Shares: GSK now holds 502,996,816 shares in Treasury.
- Treasury Percentage: Treasury shares represent 8.98% of total issued share capital and 9.86% of total voting rights.
- Shares in Issue: There are 5,100,067,123 shares in issue (excluding Treasury shares), which represents the total voting rights.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies. It is a compliance announcement confirming conformity with the Financial Services Authority's Disclosure and Transparency Rules and explicitly states it does not constitute an offer or solicitation to purchase securities.
Investor Verification Checklist
- Verify the updated total issued share capital and voting rights denominator (5,100,067,123 shares) for disclosure threshold calculations.
- Confirm the impact of the 2,400,000 share cancellation on the company's total Treasury holdings (now 502,996,816 shares).
- Note that this filing does not contain operational or financial performance data; refer to the most recent Form 20-F or interim results for revenue and profit metrics.